These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25774383)

  • 1. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors.
    Cartier E; Hamilton PJ; Belovich AN; Shekar A; Campbell NG; Saunders C; Andreassen TF; Gether U; Veenstra-Vanderweele J; Sutcliffe JS; Ulery-Reynolds PG; Erreger K; Matthies HJ; Galli A
    EBioMedicine; 2015 Feb; 2(2):135-146. PubMed ID: 25774383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntaxin 1 Ser
    Shekar A; Mabry SJ; Cheng MH; Aguilar JI; Patel S; Zanella D; Saleeby DP; Zhu Y; Romanazzi T; Ulery-Reynolds P; Bahar I; Carter AM; Matthies HJG; Galli A
    Sci Adv; 2023 Jan; 9(2):eadd8417. PubMed ID: 36630507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
    Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
    Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
    Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
    DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
    J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant.
    Wu S; Bellve KD; Fogarty KE; Melikian HE
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15480-5. PubMed ID: 26621748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
    Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
    Elife; 2021 May; 10():. PubMed ID: 34002696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylation mechanisms in dopamine transporter regulation.
    Rastedt DE; Vaughan RA; Foster JD
    J Chem Neuroanat; 2017 Oct; 83-84():3-9. PubMed ID: 28115272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells.
    Silwal AP; Lu HP
    ACS Chem Neurosci; 2018 Dec; 9(12):3117-3127. PubMed ID: 30024721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
    Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.
    Mayer FP; Stewart A; Blakely RD
    Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):206-218. PubMed ID: 37987120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine transporter proteome.
    Torres GE
    J Neurochem; 2006 Apr; 97 Suppl 1():3-10. PubMed ID: 16635244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of
    Lanzo A; Safratowich BD; Kudumala SR; Gallotta I; Zampi G; Di Schiavi E; Carvelli L
    Front Physiol; 2018; 9():576. PubMed ID: 29872404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism-Associated Variant in the SLC6A3 Gene Alters the Oral Microbiome and Metabolism in a Murine Model.
    DiCarlo GE; Mabry SJ; Cao X; McMillan C; Woynaroski TG; Harrison FE; Reddy IA; Matthies HJG; Flynn CR; Wallace MT; Wu H; Galli A
    Front Psychiatry; 2021; 12():655451. PubMed ID: 33935841
    [No Abstract]   [Full Text] [Related]  

  • 18. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
    Bolan EA; Kivell B; Jaligam V; Oz M; Jayanthi LD; Han Y; Sen N; Urizar E; Gomes I; Devi LA; Ramamoorthy S; Javitch JA; Zapata A; Shippenberg TS
    Mol Pharmacol; 2007 May; 71(5):1222-32. PubMed ID: 17267664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder.
    Hamilton PJ; Shekar A; Belovich AN; Christianson NB; Campbell NG; Sutcliffe JS; Galli A; Matthies HJ; Erreger K
    Mol Autism; 2015; 6():8. PubMed ID: 25741436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.